Skip to main content

Susan Gross

Provista Diagnostics has appointed Susan Gross as chief medical officer. In this role, Gross will oversee and guide the continued clinical progress of the company's pipeline diagnostics and identify new diagnostic approaches for development. She is currently a professor of clinical obstetrics & gynecology and women's health, pediatrics and genetics at the Albert Einstein College of Medicine in New York City. Gross joins Provista from Natera where she served as the chief medical officer. She is also the founding director of Einstein's Program for Jewish Genetic Health and founder of the Human Genetics Laboratory at Jacobi Medical Center.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.